These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7034156)
1. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose. Fölsch UR; Ebert R; Creutzfeldt W Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156 [TBL] [Abstract][Full Text] [Related]
2. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method. Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657 [TBL] [Abstract][Full Text] [Related]
3. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones. Hillebrand I; Aubell R; Boehme K; Bloom SR; Berchtold P Tohoku J Exp Med; 1983 Dec; 141 Suppl():683-6. PubMed ID: 6393444 [TBL] [Abstract][Full Text] [Related]
4. Scope and specificity of acarbose in slowing carbohydrate absorption in man. Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548 [TBL] [Abstract][Full Text] [Related]
5. Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal. O'Dea K; Turton J Am J Clin Nutr; 1985 Mar; 41(3):511-6. PubMed ID: 3883743 [TBL] [Abstract][Full Text] [Related]
6. Long-term effects of intestinal alpha-glucosidase inhibition on postprandial glucose, pancreatic and gut hormone responses and fasting serum lipids in diabetics on sulphonylureas. Uttenthal LO; Ukponmwan OO; Wood SM; Ghiglione M; Ghatei MA; Trayner IM; Bloom SR Diabet Med; 1986 Mar; 3(2):155-60. PubMed ID: 2951158 [TBL] [Abstract][Full Text] [Related]
7. Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding. Creutzfeldt W; Fölsch UR; Elsenhans B; Ballmann M; Conlon JM Scand J Gastroenterol Suppl; 1985; 112():45-53. PubMed ID: 3892654 [TBL] [Abstract][Full Text] [Related]
8. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients. Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123 [TBL] [Abstract][Full Text] [Related]
9. Manipulation of gut hormone response to food by soluble fiber and alpha-glucosidase inhibition. Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson DL; Misiewicz JJ; Alberti KG Am J Gastroenterol; 1988 Apr; 83(4):393-7. PubMed ID: 2831707 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421). Krause HP; Keup U; Puls W Digestion; 1982; 23(4):232-8. PubMed ID: 6754513 [TBL] [Abstract][Full Text] [Related]
11. Combined use of guar and acarbose in reduction of postprandial glycaemia. Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson D; Alberti KG Lancet; 1979 Nov; 2(8149):924-7. PubMed ID: 91023 [TBL] [Abstract][Full Text] [Related]
12. A glycoside-hydrolase inhibitor in treatment of dumping syndrome. McLoughlin JC; Buchanan KD; Alam MJ Lancet; 1979 Sep; 2(8143):603-5. PubMed ID: 90270 [TBL] [Abstract][Full Text] [Related]
13. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon. Ebert R; Arnold R; Creutzfeldt W Gut; 1977 Feb; 18(2):121-7. PubMed ID: 856672 [TBL] [Abstract][Full Text] [Related]
14. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance. Ebert R; Frerichs H; Creutzfeldt W Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943 [TBL] [Abstract][Full Text] [Related]
15. [Acarbose--a new therapeutic principle in diabetes mellitus therapy]. Schöffling K; Hillebrand I Dtsch Med Wochenschr; 1981 Aug; 106(35):1083-4. PubMed ID: 6114844 [No Abstract] [Full Text] [Related]
16. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man. Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P Res Exp Med (Berl); 1979 Apr; 175(1):87-94. PubMed ID: 375343 [TBL] [Abstract][Full Text] [Related]
17. Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect. Ranganath L; Norris F; Morgan L; Wright J; Marks V Diabet Med; 1998 Feb; 15(2):120-4. PubMed ID: 9507911 [TBL] [Abstract][Full Text] [Related]
18. alpha-Glucosidase inhibition in obesity. William-Olsson T Acta Med Scand Suppl; 1985; 706():1-39. PubMed ID: 3914827 [TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Qualmann C; Nauck MA; Holst JJ; Orskov C; Creutzfeldt W Scand J Gastroenterol; 1995 Sep; 30(9):892-6. PubMed ID: 8578189 [TBL] [Abstract][Full Text] [Related]
20. Blood insulin, glucose, fructose and gastric inhibitory polypeptide levels in carbohydrate-sensitive and normal men given a sucrose or invert sugar tolerance test. Ellwood KC; Michaelis OE; Hallfrisch JG; O'Dorisio TM; Cataland S J Nutr; 1983 Sep; 113(9):1732-6. PubMed ID: 6350543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]